NasdaqCM:BLFSLife Sciences
BioLife Solutions (BLFS) Faces Fairness Probes After Repligen Agrees To Buy It
Repligen has entered into a definitive agreement to acquire BioLife Solutions, the cell therapy tools company traded as NasdaqCM:BLFS.
Following the deal announcement, several law firms have launched investigations into whether the transaction is fair to BioLife Solutions shareholders.
The probes focus on the sale process, potential conflicts, and whether investors are receiving adequate value for their shares.
BioLife Solutions sits at the intersection of cell and gene therapy workflows,...